rediff.com

Mankind Pharma Q3 Profit Surges 55% to Rs 460 Cr

Share on:

By Rediff Money Desk, NEWDELHI   Jan 31, 2024 19:17

Mankind Pharma reported a 55% jump in its net profit for the third quarter ended December 2023, reaching Rs 460 crore. Revenue also saw significant growth.
Mankind Pharma Q3 Profit Surges 55% to Rs 460 Cr
Photograph: Courtesy Mankind Pharma
New Delhi, Jan 31 (PTI) Mankind Pharma on Wednesday said its consolidated net profit increased 55 per cent to Rs 460 crore for the third quarter ended December 2023.

The company had posted a net profit of Rs 296 crore in the October-December quarter of the last fiscal.

Its revenue from operations rose to Rs 2,607 crore in the period under review from Rs 2,091 crore in the year-ago period, Mankind Pharma said in a statement.

Shares of the company ended 2.79 per cent down at Rs 1,999.55 apiece on the BSE.
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.

TODAY'S MOST TRADED COMPANIES

  • Company Name
  • Price
  • Volume

More »

Moneywiz Live!